Ophtec

Ophtec is a privately held, commercial-stage ophthalmic device company with over 40 years of heritage in developing intraocular lenses and surgical solutions. Its core business focuses on two segments: cataract surgery (offering monofocal, toric, and presbyopia-correcting IOLs) and refractive surgery (with its proprietary Artisan/Artiflex phakic IOLs). The company maintains a vertically integrated model with in-house R&D and manufacturing in Groningen, and has achieved significant regulatory milestones, including the first FDA approval for a phakic IOL in 2004. Its outlook is driven by an aging population, expansion of its premium IOL portfolio, and ongoing clinical development for next-generation lenses.

Proprietary designs for intraocular lenses (IOLs), including iris-claw fixation technology (Artisan/Artiflex platform) and segmented optics technology (Precizon platform). Expertise in surgical devices like capsular tension rings (CTR) and specialized IOL/CTR delivery systems.

Ophtec competes in a global market dominated by giants like Alcon (Novartis), Johnson & Johnson Vision, and Bausch + Lomb. Its competitive edge lies in its specialized, patented phakic IOLs (Artisan/Artiflex) where it is a pioneer, and in its focused, surgeon-driven innovation for niche segments within the broader IOL market.